Adocia
ADOC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011184241 (+1 more)
- LEI:
- 969500ZL79KYH9PTYP78
- Country:
- France
- Address:
- 115 AVENUE LACASSAGNE, 69003 LYON
- Website:
- https://www.adocia.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Adocia is a clinical-stage biotechnology company founded in 2005, specializing in the development of innovative treatments for metabolic diseases, primarily diabetes and obesity. The company leverages its proprietary technology platforms and strong intellectual property to create best-in-class therapies by developing novel formulations of already-approved peptides and proteins, including insulins and other metabolic hormones. Adocia's product pipeline ranges from these advanced formulations to immunoprotective scaffolds for cell therapies. Its business model focuses on out-licensing its products and technologies to partners after establishing clinical proof-of-concept in humans.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Adocia.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-11 11:18 |
Major Shareholding Notification
Franchissements de seuil
|
French | 116.2 KB | |
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 492.1 KB | |
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 491.7 KB | |
| 2025-05-22 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 452.1 KB | |
| 2025-05-22 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 472.2 KB | |
| 2025-05-21 18:00 |
Pre-Annual General Meeting Information
Informations privilégiées / Autres communiqués
|
French | 120.9 KB | |
| 2025-05-21 18:00 |
Pre-Annual General Meeting Information
Inside Information / Other news releases
|
English | 130.5 KB | |
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 474.1 KB | |
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 473.1 KB | |
| 2025-05-14 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 576.9 KB | |
| 2025-05-14 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 531.5 KB | |
| 2025-04-30 18:00 |
Registration Form
Inside Information / Other news releases
|
English | 473.1 KB | |
| 2025-04-30 18:00 |
Registration Form
Informations privilégiées / Autres communiqués
|
French | 461.0 KB | |
| 2025-04-29 16:29 |
Annual Report (ESEF)
Document d'Enregistrement Universel 2024
|
French | 3.6 MB | |
| 2025-04-28 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 692.6 KB |
Automate Your Workflow. Get a real-time feed of all Adocia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Adocia via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-21 | N/A | Other | Buy | 51,921 | 499,999.23 EUR |
| 2024-03-21 | N/A | Other | Buy | 15,576 | 149,996.88 EUR |
| 2023-12-29 | N/A | Other | Sell | 20,000 | 236,550.00 EUR |
| 2023-10-05 | N/A | Other | Sell | 50,000 | 400,000.00 EUR |
| 2023-09-20 | N/A | Other | Sell | 36,240 | 291,376.85 EUR |
| 2023-07-28 | N/A | Other | Buy | 220,264 | 999,998.56 EUR |
| 2023-07-28 | N/A | Other | Buy | 110 | 499.40 EUR |
